Related Experiment Videos
[Vecuronium bromide in pediatric anesthesia].
S Tartari1, M Marchi, A Guberti
1Istituto di Anestesiologia e Rianimazione, Università degli Studi di Ferrara.
Minerva Anestesiologica
|May 1, 1990
Summary
Vecuronium bromide, a muscle relaxant, shows variable intubation conditions in children. Optimizing dose and administration route, like inhalation induction or priming, can improve intubation success and reduce intervals.
Area of Science:
- Anesthesiology
- Pediatric Pharmacology
Background:
- Vecuronium bromide is a neuromuscular blocking agent used in pediatric anesthesia.
- Optimizing its administration is crucial for safe and effective intubation.
Purpose of the Study:
- To evaluate the clinical characteristics of vecuronium bromide in pediatric patients.
- To determine optimal dosing and administration strategies for improved intubation conditions.
Main Methods:
- Ninety pediatric patients received vecuronium bromide via different routes and doses.
- Investigated intravenous vs. inhalation induction, dose escalation, and the 'priming principle'.
Main Results:
- A dose of 1 ED95 provided sufficient duration for short procedures but had a long induction-intubation interval.
- Inhalation induction reduced the interval compared to intravenous.
- Increasing dose to 150 mcg/kg shortened intubation time but prolonged action.
- Priming with 100 mcg/kg shortened intubation time but increased adverse reactions.
- A priming dose of 10 mcg/kg with a 4-minute interval was most advantageous.
Conclusions:
- Vecuronium bromide's efficacy in pediatric intubation is dose and administration dependent.
- Inhalation induction and specific priming strategies can optimize intubation conditions.
- Careful consideration of dose and priming is necessary to balance efficacy and adverse events.